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Abstract. X-ray irradiation of plasmid DNA in presence of platinum (II)-based compounds was car-
ried out in order to assess the radiosensitization capabilities of these drugs. In present investigations
pBR322 plasmid DNA was used to monitor the eﬀectiveness of chosen compounds in inducing strand
breaks. Samples were incubated in the presence of potential radiosensitisers: platinum (II) bromide and
cis-diamminedibromoplatinum (II). The results were examined against a common cancer chemotherapy
drug cis-diamminedichloroplatinum (II). It was found that platinum (II) bromide can greatly increase the
levels of single- and double-strand break formation observed in the irradiated samples with respect to the
samples containing platinum as a radiosensitizer only, possessing very little chemotherapeutic activity. The
suggested drugs exhibit much higher level of radiosensitivity than widely used cisplatin and thus may be
good candidates for cancer treatment.
1 Introduction
One of the major goals of modern radiotherapy is to
develop methodologies which will increase cellular DNA
damage in tumor cells using lower radiation doses such
that damage to healthy cells is reduced and the side eﬀects
on patients are mitigated. The introduction of radiosensi-
tizers into the tumour is the most successful among meth-
ods adopted nowadays. Such a treatment has been shown
to be particularly beneﬁcial in the treatment of neck,
lung, pancreas or stomach cancers [1]. Accordingly, a wide
range of radiosensitizing chemicals are being investigated,
among which platinum-containing ones have been found
to be the most successful [2,3]. It has been shown that
such compounds are coordinated by the nitrogen atoms of
purines in the DNA helix [2]. The mechanisms by which
such radiosensitization occurs are still unclear, however
recent research has highlighted that low energy electrons,
which are the most abundant species created during high
energy irradiations, may be as eﬃcient in causing dam-
age to biomolecules and DNA in particular [4–6], as the
incident radiation itself. Such secondary particle damage
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can be initiated by diﬀerent types of ionizing radiation,
e.g., X-rays or γ-rays. The single and double strand breaks
(SSBs and DSBs) produced by these secondary particles
have been shown to increase damage levels approximately
threefold, when Pt compounds are bound to DNA [6,7].
Among the most widely used cancer therapy drugs
is cisplatin, which apart from being a very eﬃcient
chemotherapeutic drug, toxic to living cells [8], can be also
used as a potential source of secondary particles, mainly
low energy electrons and radicals, emitted by high en-
ergy radiation, mainly low energy electrons and radicals.
This property of cisplatin has been investigated recently
and an increase in single and double strand breaks forma-
tion was reported [9]. The enhancement of DNA damage
upon resonant X-ray radiation in presence of platinum-
derived complexes due to the Auger eﬀects has also been
widely investigated [10,11], showing that DNA damage in-
creases upon Pt adducts that act as electron emitters.
Apart from platinum-containing drugs [12], brominated
compounds [13,14] have also been found to be eﬃcient
radio- and photosensitizers in clinical radiotherapy. There-
fore, an even more eﬃcient drug may be developed if it
contains both platinum and bromine. In the present work
we investigate Pt(II)-based molecules as possible candi-
dates for cancer drugs. To our best knowledge there have
been no studies on the eﬀect of such compounds on DNA
damage by X-rays. Although very little is known about
biochemical interactions of such compounds with DNA,
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our present studies indicate that there is a high potential
in vastly increasing the DNA damage levels upon irradia-
tion in the presence of such compounds.
2 Methodology
2.1 Sample preparation and analysis
In order to model DNA damage, a well-known cloning
vector pBR322, prepared as described previously [15], sus-
pended in ultra-high purity (UHP) H2O with pH adjusted
to 8.0 with 1 M sodium hydroxide (NaOH) was chosen.
This type of plasmid has already been widely used in ir-
radiation studies [16,17]. NaOH was chosen to stabilize
plasmid DNA under vacuum conditions as it was shown
that a lack of cations in the vicinity of phosphate back-
bone in DNA solution prior to solvent evaporation leads
to DNA strand breaks and is due to constituent water
removal from DNA [18].
Two compounds containing Pt and Br were chosen
to be tested as potential radiosensitisers: platinum (II)
bromide (PtBr2) and cis-diamminedibromoplatinum
(II) (Pt(NH3)2Br2, cis-Br-Pt). Additionally, cis-
diamminedichloroplatinum (II) (Pt(NH3)2Cl2, cis-
Pt, cisplatin) was chosen to serve as a reference for
Pt(NH3)2Br2 and allows us to quantify how the addi-
tion of bromine ions aﬀects the damage induced upon
irradiation. The compounds and reagents were purchased
from Sigma-Aldrich, UK. Cis-Br-Pt was synthesized
according to a reaction scheme published previously [19].
All compounds were dissolved in UHP water to obtain
0.1 mM solutions. The pH of all solutions was measured
and, when necessary, adjusted to 7.5–8.5 (the working
range for reactions involving DNA) with 1 M NaOH.
All solutions were ﬁltrated through a 0.2 micron syringe
ﬁlter. Complexing of DNA and Pt compounds of interest
was performed in the following way: 1 μg (0.35 pmoles)
of plasmid DNA, which contains 824 pmoles of guanine
bases, was incubated with 1 nmole of each compound
(binding site saturation conditions) in 20 μl of the total
volume of the reaction at 37 ◦C for 9 h. Some pure DNA
was also kept under the same conditions to serve as
control samples in the irradiation experiments.
Additionally, PtBr2 incubation was performed with
0.5 nmoles and 3 nmoles of the radiosensitizer and
0.35 pmoles of DNA. Samples were then subsequently sub-
jected to X-ray radiation. In order to allow for all the sensi-
tizing molecules present in solution to interact with DNA,
the incubation times were increased for lower concentra-
tions. For the highest concentration it was found that an
incubation time of 9 h is suﬃcient and no changes in su-
percoiled DNA levels were observed at longer incubation
times (data not shown). For mixtures of 0.35 pmoles of
DNA with 3 nmoles of particular sensitizer, no supercoiled
DNA could be detected after incubation when cis-Pt and
cis-Br-Pt were used. Therefore, 1 nmole of each sensitizer
was used in order to assess levels of damage upon X-ray
irradiations.
Each complex was irradiated and analyzed in triplicate
and the error bars shown in all ﬁgures represent the stan-
Fig. 1. Damage induced to plasmid DNA through the prepa-
ration procedure; quantities of main plasmid forms detected
(from left) in: (1) stock solution, (2) stock solution incubated
at 37 ◦C for 9 h, (3) stock solution mixed with PtBr2 and in-
cubated for 9 h at 37 ◦C, (4) stock solution mixed with PtBr2,
incubated for 9 h at 37 ◦C and vacuum-dried on mica, (5) stock
solution mixed with PtBr2, incubated for 9 h at 37
◦C, vacuum-
dried on mica and kept under irradiation conditions for 20 min
(no irradiation), (6) stock solution mixed with Pt(NH3)2Cl2,
incubated for 9 h at 37 ◦C, vacuum-dried on mica and kept
under irradiation conditions for 20 min (no irradiation) and
(7) stock solution mixed with Pt(NH3)2Br2, incubated for 9 h
at 37 ◦C, vacuum-dried on mica and kept under irradiation
conditions for 20 min (no irradiation).
dard deviation of the population. It was observed (Fig. 1)
that the long-term incubation of DNA at 37 ◦C introduced
around 2% loss of supercoiled form of DNA. In the case
of PtBr2, up to 5% damage was induced in DNA samples
by the presence of radiosensitizer in the incubated solu-
tions, whereas introducing of cisplatin and bromocisplatin
induced 45% and 40% of damage due to their chemical in-
teraction with DNA, respectively, throughout the whole
sample preparation procedure. For irradiation studies all
samples were deposited on freshly cleaved mica, vacuum-
dried at room temperature [20] with a small diaphragm
pump and transferred into a vacuum chamber. Three ref-
erence samples were kept under high vacuum (HV) con-
ditions (10−6 mbar) for the period of time correspond-
ing to the largest irradiation dose during the experiment.
Figure 1 shows 13% loss of the initial supercoiled DNA
form: 8% due to placing samples on mica surface and ad-
ditional 5% coming from the HV conditions. After irradi-
ation all the DNA complex samples were recovered from
mica with 5 μl of TE buﬀer and analyzed via agarose gel
electrophoresis (AGE, 1.2% gels, 1 TBE, 2 V/cm, stained
later with a SYBR Green I solution and de-stained with
a running buﬀer).
2.2 X-ray irradiation
The DNA samples were irradiated at various doses in trip-
licate using X-rays. An X-ray tube with a tungsten anode
was used, with a tube potential of 25 kV and a current
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Fig. 2. Experimental setup for X-ray irradiation studies; an
X-ray source used was an X-ray tube with a tungsten anode,
with a tube potential of 25 kV and a current of 0.50 mA to
provide a continuous X-ray spectrum up to 25 keV; delivered
dose rate was approximately 11 mGy/s.
Fig. 3. Supercoiled DNA loss as a function of X-ray radiation
dose in samples incubated with various concentrations of PtBr2
solution for various lengths of time: 9 h, 3 nmoles (), 12 h,
1 nmole (•) and 18 h, 0.5 nmole (), compared with pure DNA
(). Curves are guides to the eye.
of 0.50 mA to provide a continuous X-ray spectrum up to
25 keV. The X-ray tube was capable of delivering a dose
rate of approximately 11.5 mGy/s. Such an arrangement
(depicted in Fig. 2) allowed irradiation of the samples with
low energy X-rays, knowing that predominant lines in the
spectrum will be Lα, Lβ and Mα with energies approxi-
mately equal 8.36 keV, 9.8 keV and 1.8 keV, respectively.
3 Results and discussion
Figures 3 and 4 present the loss of supercoiled DNA form
and the appearance of DSBs upon X-ray irradiation in
presence of various quantities of PtBr2, respectively. The
level of damage obtained increases with the quantity of ra-
diosensitizing molecules present in the sample. An increase
in the levels of damage can be seen for samples incubated
Fig. 4. Yields of DSB as a function of X-ray radiation dose in
samples incubated with various concentrations of PtBr2 solu-
tion for various lengths of time: 9 h, 3 nmoles (), 12 h, 1 nmole
(•) and 18 h, 0.5 nmole (), compared with pure DNA ().
Curves are guides to the eye.
Fig. 5. Loss of supercoiled DNA form as a function of X-ray
radiation dose in samples incubated with 1 nmole of PtBr2
solution for 0 h (), 1 h (•) and 12 h (). Curves are guides
to the eye.
with PtBr2 with respect to pure DNA that was kept under
incubation conditions for 18 h and then irradiated.
Additionally, various incubation times for the same
amount of PtBr2 were tested. Samples of DNA mixed with
1 nmole of sensitizer were subjected to X-ray radiation di-
rectly after mixing, after 1 h and 12 h of incubation and
subsequent vacuum-drying. The loss of supercoiled DNA
form is shown in Figure 5, while the appearance of DSBs
is depicted in Figure 6. It can be seen that a very small
radiosensitizing eﬀect is present after instant irradiation.
The numbers of DSBs present in the sample before irradia-
tion and formed upon photon interaction increase with in-
cubation time at higher concentrations of PtBr2, whereas
when there was no incubation or the incubation time was
short, the results are comparable.
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Fig. 6. Appearance of DSB as a function of X-ray radiation
dose in samples incubated with 1 nmole of PtBr2 solution for
0 h (), 1 h (•) and 12 h (). Curves are guides to the eye.
Fig. 7. Supercoiled DNA loss as a function of X-ray radiation
dose for samples incubated for 12 h with 1 nmole of cis-Pt (),
cis-Br-Pt (•) and PtBr2 (). Curves are guides to the eye.
Finally, the results obtained for DNA complexes with
PtBr2 were compared with widely used cisplatin and its
brominated analogue. Signiﬁcant levels of damage can be
obtained only in case when PtBr2 is used as radiosensitizer
at higher doses (Fig. 7), whereas the damage levels ob-
tained for cis-Pt and its brominated derivative result pre-
dominantly from the internal binding to DNA and possess
no or a very little eﬀect on the double-helix, when also ex-
posed to X-rays. Moreover, an increase in the DSB forma-
tion (Fig. 8) upon irradiation was observed as a function
of radiation dose only for DNA samples incubated with
PtBr2, whereas in two other cases DSB levels remained
unchanged during irradiation.
The irradiation carried in presence of PtBr2 shows sig-
niﬁcantly high levels of damage induced with respect to
pure plasmid molecules (up to 60%, Fig. 3). This com-
Fig. 8. Percentage amount of linear DNA as a function of
X-ray radiation dose for samples incubated for 12 h with
1 nmole of of cis-Pt (), cis-Br-Pt (•) and PtBr2 (). Curves
are guides to the eye.
pound, when irradiated, also caused a considerable in-
crease in levels of the double strand breaks (Fig. 4).
Furthermore, in comparison to widely used cisplatin and
its brominated analogue a higher radiosensitivity was
obtained for complexes with PtBr2 (Figs. 7 and 8).
Comparing our results with the ones obtained for cis-
platin [11], it can be seen that for non-modiﬁed DNA the
supercoiled form loss is at the level of 10% in our measure-
ments over the whole range, whereas in case of the pre-
viously published experiments [11], the increase reaches
60%. This clearly shows that the doses of radiation used
in our experiments are signiﬁcantly lower, than in case
of the previous experiments [11], thus no radiosensitivity
was observed for DNA irradiated in presence of cis-Pt and
cis-Br-Pt. Therefore, there is a huge increase of damage
levels with signiﬁcantly lower dose of delivered radiation
for PtBr2, when the loss of supercoiled DNA reaches up
to 60% of the initial form for the highest concentration of
the radiosensitizer (Fig. 3).
Apart from an increase of SSBs levels, a substantial
increase in DSBs levels was seen for PtBr2, which is an
important feature for a potential radiosensitizer. For the
investigated PtBr2 compound the number of DSBs almost
doubled after the irradiation with respect to the initial
4.5% of damage, whereas for cisplatin and its brominated
analogue the damage levels remained unchanged over the
irradiation period.
4 Conclusions
The mechanism by which DNA damage is induced by ra-
diation in presence of PtBr2 needs to be explored, yet
it is believed that in this case the most probable path-
way for DNA damage is due to the secondary particles
(low energy electrons and OH radicals) that are formed
upon incident high energy radiation. It has been shown
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that the 12.5 eV electrons tend to form H2O+ ions as a
product of the ionization of the constituent gas-like wa-
ter molecules [21], which may lead to further DNA strand
breakage due to secondary electrons. Moreover, at higher
electron energies water molecules can dissociate and pro-
duce hydroxyl radicals.
It is believed that the observed damage for PtBr2 orig-
inates from bromine rather than platinum. In cases of cis-
Pt and cis-Br-Pt no damage was induced upon irradia-
tion. It is known that cis-Pt forms coordinative bonds with
DNA through exchange of its chlorine atoms [22] and thus
halogens are not expected to be present in close proximity
of DNA. For cis-Br-Pt the mode of binding is expected
to be similar. PtBr2 is a hydrophobic compound, there-
fore hydrolysis of bromine is not expected in this case.
Although the biochemical interaction of PtBr2 with DNA
remains unclear, it can be seen from comparison with data
obtained for other compounds that it is the presence of
bromine that is causing the diﬀerence. Also, the X-ray
source used in the experiment does not produce emission
lines that possess energy high enough to cause Auger emis-
sion from platinum. In case of non-resonant processes, the
radiation doses used in the experiment are far too low for
cis-Pt as seen in case of other studies [11].
Due to the positive electron aﬃnity of bromine atom
(3.363 eV), low energy electrons may easily be captured
by Br and thus form negative ions. Dissociative electron
attachment to PtBr2 at electron energies from 0 to 10 eV
has already been studied [23] and Br− anion formation
has been reported. The predominant channels for the dis-
sociation of PtBr2 molecule were found at (1) 1.2 eV and
ascribed to Br−+PtBr formation and (2) 7.0 eV, where
Br−+Pt+Br dissociation mechanism was assigned.
Another possible damage pathway concerns exited
states of bromine atom, formed upon incident radia-
tion [24]. These excited states may release additional elec-
trons when colliding with low energy electrons and thus
enchance the damage levels. It is also worth noticing that
Mα1 emission line from the tungsten target (1.779 keV)
coincides with LI edge energy of bromine (1.782 keV) and
this may cause a photoelectron emission from bromine
atoms.
The way PtBr2 interacts with DNA is still unknown.
In order to explore the possible binding pathways we plan
to investigate in the near future PtBr2-DNA complexes
by means of X-ray photoelectron spectroscopy (XPS).
In conclusion, although the mechanism is not yet fully
understood, the present data implies that there is a po-
tential for suggested PtBr2 compound to be used as
radiosensitizer in cancer therapy.
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